Frontiers in Oncology
IF
4.85
Papers
5147
Papers 9964
1 page of 997 pages (9,964 results)
Newest
Source
#1Servando Hernandez Vargas (University of Texas at Austin)
#2Christie LinH-Index: 3
Last. Ali AzhdariniaH-Index: 22
view all 0 authors...
Source
Source
#1Yuan Meng (Peking Union Medical College)
#2Biping DengH-Index: 6
Last. Alex H. Chang (Tongji University)H-Index: 6
view all 0 authors...
Chimeric antigen receptor (CAR) T-cell therapy is a new promising treatment for refractory or relapsed (r/r) B-cell non-Hodgkin lymphoma (B-NHL), and has been widely used in recent years. However, the overall response rate (ORR) is much lower in B-NHL than in r/r B acute lymphoblastic leukemia (B-ALL) patients. Sequential infusion of CD22 CAR-T after responding to prior CD19 CAR-T therapy improved the complete remission (CR) rate of B-NHL reported by our group, while there were still some advanc...
Source
#1Linqin Wang (ZJU: Zhejiang University)H-Index: 1
#2Ruimin HongH-Index: 3
Last. Alex H. Chang (Tongji University)H-Index: 6
view all 0 authors...
Source
Source
Source
#1Shuai Zhao (MOE: Chinese Ministry of Education)
#2Ling Lv (PRC: China Medical University (PRC))H-Index: 2
Last. Cheng-Gang JiangH-Index: 9
view all 0 authors...
Source
Source
#2Junjie MiaoH-Index: 4
Last. Jianrong DaiH-Index: 13
view all 0 authors...
Source
12345678910
Top fields of study
Cancer
Pathology
Oncology
Immunology
Cancer research
Medicine
Biology